In response to the IV shortage due to Hurricane Helene and Milton, the MN Board of Pharmacy is exercising temporary enforcement discretion to actively licensed pharmacies approved for sterile product compounding as long as the licensed pharmacy is able to meet the conditions set forth in the FDA’s Immediately-in-effect-guidance document: “Temporary Policies for Compounding Certain Parenteral Drug Productions.”

Before providing the drug product to the hospital or health system, a State-licensed pharmacy must notify the Minnesota Board of Pharmacy that they will follow the FDA’s guidance documents and cease once the shortage caused by the Hurricanes has been resolved and provide a list of pharmacies that will be involved.

Beware of scam artists posing as Board members, staff, or law enforcement agents.

Report possible fraudulent attempts to company managers, law enforcement, and either the Federal Trade Commission or the Federal Bureau of Investigation’s Internet Crime Complaint Center, dependent on the nature of the scam. If you have concerns about a suspicious phone call, hang up and call the Board of Pharmacy directly at 651-201-2825.

For more information about where to report and how to protect yourself from scams, visit www.usa.gov/scams-and-fraud.